Strategic partnership PSI recently partnered with AFSBio Inc., signaling openness to distribution and co-development opportunities. Target potential alliances with firms seeking specialized molecular separation reagents and GMP manufacturing capabilities in North America.

GMP sterile producer Operate GMP, FDA and DEA registered facilities in Freehold, NJ, with sterile manufacturing for pharmaceutical and diagnostic clients. This positions PSI as a reliable supplier for regulated biotech workflows requiring quality compliance and validated processes.

Molecular separation leader A broad product portfolio focused on DNA, RNA, protein purification and labeling tools (Centri·Sep, Centri·Spin, Pro·Spin, Fluoro·Spin, PCR·96, etc.). Opportunities to cross-sell to labs and contract manufacturers needing turnkey purification solutions and high-performance reagents.

Growth and reach Small team size (2-10 employees) with a growing facility suggests capacity for scaled partnerships, reseller programs, and OEM manufacturing agreements to extend reach without heavy capital investments.

Regulatory credibility FDA and DEA registration coupled with GMP focus enhances credibility for pharma/diagnostic customers and may open doors to larger organizations seeking validated suppliers for compliant molecular biology workflows.